Another NameQuizartinib、Vanflyta、奎扎替尼
IndicationsUsed for the treatment of relapsed or refractory FLT3-ITD mutation positive acute myeloid leukemia.
Reg No.06 L 1105/24
Inspection No.1230-24
WhatsApp:
